Douglas Mulinix, MD
Psychiatry · Danville, INNPI 1346284973
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $19,204 of the $23,115 with a category attached, or 83.1%. 40 manufacturers reported payments, led by AbbVie at 28.2% of the total. Reporting peaked in 2021 at $7,923 and has fallen 63.2% since, to $2,918 in 2025. Among psychiatry clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,473 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$2K
- Neos Therapeutics, LP$1K
- Bausch Health US, LLC$1K
- Tris Pharma Inc$1K
- plus $10K from 34 others
What the payments were for
- Speaking & faculty fees$3,77516%
- Food & beverage$19,20483%
- Education$1371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$3,995
- ABILIFY ASIMTUFII$125
- COBENFY$116
- REXULTI$101
- CAPLYTA$101
How this compares
$23,115 in reported general payments places this provider in the 95th percentile of 514 psychiatry providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 66 | $94,534 |
| ClozarilClozapine | 12 | $39,790 |
| TrintellixVortioxetine Hydrobromide | 47 | $33,705 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 66 | $11,958 |
| VyvanseLisdexamfetamine Dimesylate | 20 | $7,593 |
| Lurasidone Hcl | 74 | $5,529 |
| Dyanavel XrAmphetamine | 11 | $4,705 |
| Bupropion XlBupropion Hcl | 218 | $4,411 |
| Duloxetine Hcl | 202 | $4,399 |
| Buspirone Hcl | 260 | $2,920 |
| Quetiapine Fumarate | 124 | $2,728 |
| Aripiprazole | 134 | $2,510 |
| Lamotrigine | 224 | $2,021 |
| Trazodone Hcl | 190 | $1,676 |
| Methylphenidate Hcl | 56 | $1,538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $6,519 | $94,53466 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $632 | $41,29867 claims |
| Tris Pharma IncDyanavel Xr | $1,154 | $4,70511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Danville
- Rick RobertsonDanville$36K
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.